Document is current
Any future updates will be listed below
-
Authors
Brooks, Eric D.
Wang, Xiaochun
De, Brian https://orcid.org/0000-0003-3468-3359
Verma, Vivek
Williamson, Tyler D.
Hunter, Rachel
Mohamed, Abdallah S. R.
Ning, Matthew S.
Zhang, Xiaodong
Chang, Joe Y.
-
Funding
Funding for this research was provided by:
National Cancer Institute, National Institutes of Health (P30 CA016672)
- License Information
-
More Information
Article History
Received: 6 October 2021
Accepted: 23 December 2021
First Online: 6 January 2022
Declarations
:
: The Institutional Review Board Committee at MD Anderson Cancer Center approved our request to review the medical records of these patients (RCR05-0263). The need for informed patient consent was waived, as this was a retrospective review and no identifiable patient information is included in this report. This study was conducted in accordance with the ethical standards of the Declaration of Helsinki and its later amendments.
: Not applicable.
: Dr. De reports honoraria from Sermo, Inc. Dr. Chang reports grant funding from Bristol Meyers Squibb and honoraria from Varian Medical Systems. Additionally, Dr. Chang is a shareholder for Global Oncology One, reports serving as a consultant for AstraZeneca, and reports serving as an advisory board member for Legion. All reported conflicts are outside the current work.
